Coya Therapeutics (COYA) EPS (Basic) (2022 - 2026)
Coya Therapeutics (COYA) reported EPS (Basic) of -$0.32 for Q1 2026, up 27.17% on a YoY basis from -$0.25 in Q1 2025, and up 37.85% sequentially from -$0.51 in Q4 2025.
Coya Therapeutics (COYA) EPS (Basic) (2022 - 2026) Analysis & Trends
Coya Therapeutics (COYA) has 5 years of EPS (Basic) data on file, last reported at -$0.32 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 27.17% year-over-year to -$0.32; the trailing twelve-month figure through Mar 2026 stood at -$1.18 (up 35.86% YoY), and the FY2025 full-year result was -$1.27, down 30.23% from the prior year.
- EPS (Basic) advanced to -$0.32 in Q1 2026, from -$0.51 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.19 in Q2 2024 to a low of -$1.33 in Q2 2022.
- A 5-year average of -$0.57 and a median of -$0.45 in 2023 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) soared 67.67% in 2023 and sank 113.74% in 2024, its largest moves.
- Tracing COYA's EPS (Basic) over 5 years: stood at -$1.16 in 2022, then soared by 67.67% to -$0.37 in 2023, then slumped by 113.74% to -$0.8 in 2024, then jumped by 36.08% to -$0.51 in 2025, then jumped by 37.85% to -$0.32 in 2026.
- Business Quant data shows COYA's EPS (Basic) at -$0.32 in Q1 2026, -$0.51 in Q4 2025, and -$0.29 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.55 |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | -0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | -0.80 |
| Sep 30, 2024 | -0.55 |
| Jun 30, 2024 | -0.19 |
| Mar 31, 2024 | -0.35 |
| Dec 31, 2023 | -0.37 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.45 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -1.16 |
| Sep 30, 2022 | -1.03 |
| Jun 30, 2022 | -1.33 |
| Mar 31, 2022 | -0.66 |